PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17699663-4	2007	Two weeks after a methamphetamine binge (4 x 10 mg/kg, i.p., at 2 h intervals), GDNF(+/-) mice had a significantly greater reduction of tyrosine hydroxylase immunoreactivity in the medial striatum, a proportionally greater depletion of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the striatum, and a greater increase in activated microglia in the substantia nigra than wild-type mice.	3,4-Dihydroxyphenylacetic Acid	253-279	glial cell line derived neurotrophic factor	Mus musculus	80-84	
17699663-4	2007	Two weeks after a methamphetamine binge (4 x 10 mg/kg, i.p., at 2 h intervals), GDNF(+/-) mice had a significantly greater reduction of tyrosine hydroxylase immunoreactivity in the medial striatum, a proportionally greater depletion of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the striatum, and a greater increase in activated microglia in the substantia nigra than wild-type mice.	3,4-Dihydroxyphenylacetic Acid	281-286	glial cell line derived neurotrophic factor	Mus musculus	80-84	
17699663-5	2007	At 12 months of age, methamphetamine-treated GDNF(+/-) mice exhibited less motor activity and lower levels of tyrosine hydroxylase-immunoreactivity, dopamine, DOPAC, and serotonin than wild-type mice.	3,4-Dihydroxyphenylacetic Acid	159-164	glial cell line derived neurotrophic factor	Mus musculus	45-49	
16437537-5	2006	Also, the response of extracellular accumbal DOPAC to acute morphine was significantly altered in the GDNF+/- mice.	3,4-Dihydroxyphenylacetic Acid	45-50	glial cell line derived neurotrophic factor	Mus musculus	102-106	
15978005-3	2005	GDNF treatment (100 ng/mL) increased dopaminergic neuron soma size (up to 43%) and DOPAC production (approximately three-fold), but not the number of dopamine neurons in control cultures.	3,4-Dihydroxyphenylacetic Acid	83-88	glial cell line derived neurotrophic factor	Mus musculus	0-4